View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.

Medical Crossfire®: Impact of COVID-19 on Neutropenia Management in Cancer Care and the Advent of Novel Treatment Approaches

Medical Crossfire®: Impact of COVID-19 on Neutropenia Management in Cancer Care and the Advent of Novel Treatment Approaches

Tuesday, June 30, 2020

Live Webcast!: 8:00 PM – 9:30 PM ET


The current coronavirus disease 2019 (COVID-19) health crisis has posed several challenges for oncologists who are caring for immunocompromised patients. Neutropenia is a complication of anticancer therapy, and new guideline recommendations are available for its management in the context of the COVID-19 pandemic.

This live webcast features a panel of experts who will address the latest advances on the management of neutropenia in cancer care. The faculty will discuss various aspects of neutropenia including current treatments, new approaches to management, and the challenges that the COVID-19 crisis has imposed on the care of patients with neutropenia. They will share patient case scenarios commonly encountered in clinical practice and will provide the learners with practical methods to optimize health outcomes for patients experiencing neutropenia in the oncology setting.

Benefits of Attending

  • Learn about emerging treatments for neutropenia
  • Incorporate the latest clinical data for neutropenia into your practice
  • Hear how experts are managing patient care during the COVID-19 health crisis

Acknowledgement of Commercial Support

This activity is supported by an educational grant from BeyondSpring Pharmaceuticals, Inc.

Target Audience

This educational activity is directed toward medical oncologists, hematologists, fellows, surgical oncologists and radiation oncologists interested in treatment and management of patients with cancer. Nurse practitioners, nurses, physician assistants, researchers, and other healthcare professionals interested in the treatment of cancer may also participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Determine patients with cancer at low-, intermediate-, and high-risk to develop neutropenia, including febrile neutropenia.
  • Discuss the impact of COVID-19 on neutropenia care for patients with cancer and updates made to current treatment guidelines in the context of management during the COVID-19 pandemic.
  • Discuss unmet gaps in the management of neutropenia and the role of emerging therapies to bridge those unmet clinical needs
  • Create proactive management plans focused on pretreatment against neutropenia, and approaches to treat patients when neutropenia occurs.

Program Chair

Douglas W. Blayney, MD
Douglas W. Blayney, MD
Professor of Medicine, Oncology
Breast specialist
Stanford University Medical Center
Stanford, CA


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By